Takaki Hiwasa

Chiba University

Japan

Research Interests

Explore related searches

Professors in Japan Professors in Immunology Immunology professors in Japan

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

Articles (10)

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Collaborators (3)

Eiichiro Nishi

Professor

Shiga University of Medical Science

JAPAN

View details

Tomohiko Yoshida

Associate Professor

International University of Health and Welfare Narita Hospital

JAPAN

View details

Shigeyuki Yokoyama

Head of RIKEN Yokoyama Laboratory

JAPAN

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Takaki Hiwasa

Research Interests

Explore related searches

Contact this professor

Articles (10)

JMJD6 Autoantibodies as a Potential Biomarker for Inflammation-Related Diseases

Serum anti‑KIAA0513 antibody as a common biomarker for mortal atherosclerotic and cancerous diseases

Stage-Specific Alteration and Prognostic Relationship of Serum Fumarate Hydratase Autoantibodies in Gastric Cancer.

Atherosclerosis-related biomarker PABPC1 predicts pan-cancer events.

Combination of high anti-SKI and low anti-TMED5 antibody levels is preferable prognostic factor in esophageal carcinoma.

Combinational antibody detection approach increases the clinical validity of colorectal cancer screening.

Serum anti-PCK1 antibody levels are a prognostic factor for patients with diabetes mellitus.

GADD34 activates p53 and may have utility as a marker of atherosclerosis.

Analysis of patients with colorectal cancer shows a specific increase in serum anti-ING1 autoantibody levels.

Association of high proprotein convertase subtilisin/kexin type 9 antibody level with poor prognosis in patients with diabetes: a prospective study.

Collaborators (3)

Eiichiro Nishi

Tomohiko Yoshida

Shigeyuki Yokoyama

Make your next move.